Considerable evidence indicates that diacylglycerol (DAG) generation at the immunological synapse (IS) determines T cell functions by regulating the duration and amplitude of Ras/ERK signals. The exact mechanism by which DAG regulates Ras/ERK activation downstream of the T cell receptor (TCR) nonetheless remains poorly understood. Here we characterize PKCa as a previously unrecognized component of the machinery that translates cell receptor occupancy into Ras/ERK-propagated signals. We show transient translocation of PKCa to the IS, mediated by DAG generation at the contact area. Diacylglycerol kinase (DGK)f negatively regulated PKCa translocation kinetics, whereas PKCa activity limited its own persistence at the IS. Coordinated activation of DGKf and PKCa in response to antigen recognition regulated the amplitude and duration of Ras/ERK activation; this in turn mediated early processes of T cell surface proteolysis such as L-selectin shedding. Analysis of DGKf-deficient mice further showed that increased DAG signaling is translated to downstream elements of this pathway, as reflected by enhanced PKCa-dependent L-selectin shedding. We propose that early activation of a DAG-PKCa axis contributes to the mechanisms by which antigen affinity translates into TCR biological responses.
Introduction
In the adaptive immune response, the fine-tuning of T cell activation is essential to prevent autoimmune disease, inflammation or allergic response, and for some anti-tumor therapies. The ability to manipulate the T cell response is thus a major objective in the clinical treatment of these pathologies. T cell activation is initiated after lymphocyte contact with antigenpresenting cells (APC). Specific antigen recognition by the T cell receptor (TCR) organizes a structured signaling platform at the T cell/APC contact area, known as the immune synapse (IS). Recruitment of PLCc (phospholipase C c) to the IS allows rapid hydrolysis of PIP2 (phosphatidylinositol 4,5-bisphosphate), which results in intracellular Ca 2+ release and DAG (diacylglycerol) generation. Polarized DAG generation at the IS allows selective activation of a broad range of effectors, including kinases of the PKC and PKD (protein kinase C, D) families, the Ras GEF (guanine nucleotide exchange factor) RasGRP1, and the Rac GAP b2chimaerin . Local activation of these proteins initiates a cascade of signals that control the Ras/ERK/AP-1 and CARMA/NFkB pathways, which act in concert with the Ca 2+ /calcineurin/NFAT pathway to ensure onset of the T cell activation program. Strict control of DAG levels is necessary during IS formation to provide the signal location and intensity needed for a correct immune response. Diacylglycerol kinases (DGK) convert DAG to phosphatidic acid (PA), thus acting as negative regulators of DAG-mediated signals. T lymphocytes express at least two DGK isoforms (a and f), of which DGKf is the major form responsible for DAG metabolism at the IS .
The PKC Ser/Thr protein kinases are principal DAG targets. In mammals, this family is composed of ten members, grouped as classical (cPKC), novel (nPKC) and atypical (aPKC) based on regulatory domain structure and ability to respond to DAG and Ca 2+ (Newton, 2010) . The PKC localize predominantly in the cytosol of resting cells, where they are catalytically inactive due to autoinhibition by their pseudosubstrate domain. Following receptor activation, PKC isotype-specific signals facilitate membrane translocation, promoting conformational changes that displace the pseudosubstrate moiety from the catalytic cleft and allow phosphorylation of specific substrates. The novel PKCh is abundant in hematopoietic cells and is the only PKC selectively recruited to the IS through interaction with the costimulatory molecule CD28. PKCh mediates activation of the CARMA/NFkB axis, leading to enhanced IL-2 production (Huang et al., 2002; Kong et al., 2011; Matsumoto et al., 2005) . PKCh-deficient mice have severe defects in Th2-and Th17-mediated responses and in T regulatory cell development. These mice nonetheless develop a normal protective Th1 immune response, as they are able to clear viral infections, and have intact CD8 + effector memory responses (Hayashi and Altman, 2007; Marsland et al., 2005) .
PKCa is proposed to act in concert and/or in alternative pathways with PKCh to regulate the IkB/NFkB axis (Trushin et al., 2003) ; it has additional functions including HIV reactivation (Trushin et al., 2005) , TCR downregulation (von Essen et al., 2006) and granule exocytosis (Grybko et al., 2007) . PKCa-deficient mice have a severe defect in the Th1 response and IFNc secretion (Pfeifhofer et al., 2006) . The phenotype of PKCh/PKCa double-deficient mice (Gruber et al., 2009) , as well as the potent immunosuppressive effect of the dual PKCh/PKCa inhibitor AEB071 (sotrastaurin) (Baier and Wagner, 2009) , further suggest that these two kinases may have non-redundant functions in the regulation of T cell activation.
Here we report rapid, transient PKCa recruitment to the IS during T cell/APC encounter, through a mechanism dependent on DAG generation and kinase activity. We show that DGKfmediated DAG consumption regulates local PKCa recruitment at the T cell/APC contact area. Pharmacological and genetic approaches further demonstrate that PKCa is necessary for TCRmediated early activation of the Ras/ERK axis and the regulation of cell surface protein proteolysis, as measured by L-selectin shedding. Analysis of DGKf-deficient mice suggests that the role of DGKf in T cell hyperactivation can be attributed at least in part to PKCa activation. Our results identify PKCa as a component of the DAG-based signalosome induced by antigen recognition, and clarify the mechanisms by which DAG generation at the IS regulates T cell function.
Results

PKCa-GFP localizes at the IS following TCR stimulation
We previously detected PKCa in activated TCR complexes, which suggested that PKCa is recruited to the TCR/APC contact site . To study endogenous PKCa translocation dynamics in response to TCR-mediated signals, we used classical membrane fractionation assays and assessed translocation kinetics in Jurkat T cells stimulated with anti-CD3/ CD28 antibodies (Fig. 1A) . Membrane localization was detected from the first minute of TCR activation, and then decreased with kinetics that closely resembled that of PLCc phosphorylation and membrane recruitment. Quantification of plasma membrane recruitment suggested that PKCa translocation kinetics was Fig. 1 . PKCa translocates to the plasma membrane and the IS in response to TCR activation. (A) Jurkat T cells were stimulated with 5 mg/ml anti-CD3/ CD28 antibodies for indicated times or with 200 ng/ml PMA for 30 minutes, and crude membrane fractions isolated. Membrane and cytosolic fractions were probed with specific antibodies; human transferrin receptor (hTfR) and GAPDH were used as markers of membrane and cytosolic fractions, respectively. (B) Normalized plasma membrane recruitment is shown for each time point (normalized to time 0). (C) Videomicroscopy of GFP-fused PKCa and PKCh constructs transiently expressed in Jurkat T cells during antigen presentation. Raji B cells, CMAC-prestained and pulsed with 1 mg/ml SEE (blue), were used as APC (antigen-presenting cells). APC were added as droplets to adhered T cells to capture initial IS formation, and frames were acquired every 10 seconds for 12.5 minutes; consecutive frames taken every 30 seconds are shown. (D) Accumulation of PKCa (gray box) and PKCh at the IS was measured as the IS:cytosol fluorescence intensity ratio during the course of time-lapse acquisition (n$6 videos), using ImageJ software (v1.45q). (E) Representative view of PKCa and actincherry translocation dynamics to the IS. Videomicroscopy of Jurkat T cells transfected with PKC-GFP and actin-cherry, stimulated 24 hours post-transfection with SEE-loaded APC. Contact between APC and T cell is shown for consecutive frames. Scale bars: 10 mm (C); 2 mm (E). similar to that of PKCh; however, the latter showed sustained accumulation at the membrane (Fig. 1B) . Complete plasma membrane translocation of PKCa was observed after phorbol 12-myristate 13-acetate (PMA) treatment, which was used as a control.
To study PKCa dynamics after T cell activation, we adopted a T cell stimulation model, using antigen-pulsed Raji B cells as APC, and time-lapse confocal microscopy analysis of T cells expressing PKCh or PKCa fused to green fluorescent protein (GFP). GFP-PKCh translocation was rapid, within the first 40-60 seconds after initial cell-cell contact, and the kinase remained at the IS at least 15 minutes after SEE presentation, as reported (Fig. 1C, bottom) (Yokosuka et al., 2008) . Whereas non-loaded APC did not promote PKCa relocalization to the T cell-APC contact area (Fig. 1C, top) , we observed rapid PKCa-GFP translocation to the IS at 20-40 seconds after initial contact with SEE-loaded APC. Quantification analysis showed that the translocation kinetics of PKCa were different from that of PKCh as IS PKCa localization was lost by 120 seconds after synapse formation, with an average accumulation time of 60-100 seconds (Fig. 1D ). In addition, PKCa-GFP translocation closely mimicked the kinetics of actin polymerization at the initial stages of IS formation, as shown by PKCa-GFP coexpression with actin fused to the cherry fluorescent tag (actin-cherry) ( Fig. 1E ; supplementary material Movie 1). These data indicate the rapid translocation dynamics of PKCa, and suggest that the two PKC isoforms are subject to distinct regulatory and recruitment mechanisms to the IS during T cell activation.
To test whether endogenous PKCa is also recruited to the IS, Jurkat T cells incubated with SEE-loaded Raji B cells were fixed and stained with anti-PKCa antibody (supplementary material Fig. S1A ). We measured localization of phosphorylated PKCa in the C-terminal 'turn motif' (PKCa-Thr-638) to trace the mature form of PKCa (supplementary material Fig. S1B ). We observed pPKCa accumulation at the IS in 43% of the T/B cell conjugates. Thr-638 is thought to be an autophosphorylation site and reflects the activated PKCa form at the IS (Parekh et al., 2000) . We also evaluated PKCa localization in primary mouse T cells, using the OTI mouse model of transgenic TCR restricted to MHC class I (Hogquist et al., 1994) . As in Jurkat T cells, some conjugates showed PKCa-positive IS, which coincided with accumulation of PKCh, used as an IS marker (supplementary material Fig. S1C ).
DGKf limits PKCa-GFP translocation to the IS during antigen presentation
Membrane translocation of classical PKC comprises the initial Ca 2+ -mediated exposure of the DAG-binding C1 regions, which promote stabilization of these proteins in an active conformation at the membrane (Gallegos and Newton, 2008) . To determine the Ca 2+ contribution, we examined PKCa translocation to the IS in cells in which Ca 2+ influx was prevented by preincubation with the Ca 2+ chelator EGTA. Cells were pretreated with EGTA for 30 minutes prior to addition of SEE-loaded APC. In these conditions, PKCa-GFP was unable to translocate to the IS and remained cytosolic during antigen presentation ( Fig. 2A,B) , confirming the requirement for Ca 2+ generation. We compared the dynamics of PKCa recruitment to the IS with the DAG metabolic rate at this site, using a fluorescent DAG sensor (Carrasco and Merida, 2004) fused to the cherry tag (cherryC1ab). As reported , the sensor accumulated at the IS after T cell/APC conjugation (Fig. 2C) . PKCa-GFP colocalized with cherry-C1ab, although detailed analysis of translocation dynamics showed that the DAG sensor reached the IS more rapidly than PKCa-GFP (Fig. 2D ). This indicates that DAG increase at the IS precedes PKCa recruitment. We recently reported a critical role for DGKf in the control of DAG levels at the IS . To determine whether DAG can regulate PKCa localization, we analyzed the consequences of altering DAG metabolism at the IS. PKCa-GFP was co-expressed with cherry (Fig. 3A) or DGKf fused to cherry (cherry-DGKfWT) (Fig. 3B) in Jurkat T cells, which were then exposed to SEE-loaded APC. Cherry-DGKf overexpression did not affect PKCa-GFP IS localization, but reduced PKCa-GFP persistence at the IS by ,70% compared to controls (10-20 seconds versus 60-80 seconds IS retention time) ( Fig. 3B-D ; supplementary material Movie 2). This effect was due to DAG depletion at the IS, since expression of the kinase-inactive DGKf mutant fused to cherry (cherry-DGKfKD), which no longer catalyzes DAG phosphorylation into PA (Santos et al., 2002) , did not alter PKCa translocation dynamics to the IS ( Fig. 3C,D ; supplementary material Movie 3).
To further assess the DGKf contribution, we measured the effect of DGKf knockdown on PKCa-GFP translocation to the IS (Fig. 3E) . Western blot analysis confirmed that both, the long and short DGKf isoforms were efficiently silenced. Control shRNAtransfected cells conjugated with SEE-pulsed APC showed transient PKCa-GFP translocation to the IS, with kinetics similar to that of cells expressing PKCa-GFP alone (Fig. 3F, top;  supplementary material Movie 4). In DGKf knocked-down cells, PKCa-GFP accumulation at the IS was sustained up to 240 seconds from the time of initial cell-cell contact (Fig. 3F, G; supplementary material Movie 5) . After this time, PKCa-GFP lost its IS localization. These data suggest that DGKf negatively regulates PKCa translocation to the IS through local control of DAG metabolism.
PKCa dissociation from the membrane is regulated by enzyme activity Polarized DAG production is preserved throughout the duration of lymphocyte contact with the APC, whereas PKCa localizes transiently at this site; this suggests that additional mechanisms regulate PKCa dissociation from the IS. Studies of classical PKC show that these isoforms are unstable in their open/active conformation. They have lower affinity for DAG than novel PKC, and are prone to C-terminal autophosphorylation, which promotes intramolecular interactions that clamp the pseudosubstrate region and release the enzyme from the membrane (Newton, 2003) .
We used pharmacological assays to determine the requirements for PKCa catalytic activity in subcellular regulation (Fig. 4) . PKCa-GFP translocation dynamics in cells pretreated with the broad PKC inhibitor bisindolylmaleimide (BIM) showed early IS recruitment during antigen presentation. Unlike vehicle-treated cells, however, this accumulation was sustained ( Fig. 4A ; supplementary material Movie 6). We also tested specific inhibitors for classical PKC (Gö6976) and for novel PKC (rottlerin) (Fig. 4A) . The effect of Gö6976 treatment was similar to that of BIM, whereas rottlerin treatment did not alter PKCa translocation, which followed the same kinetics as vehicle-treated cells (Fig. 4B,C) . These data thus support the current model for PKCa recruitment to the IS, in which enzyme autophosphorylation leads to a conformational change that competes with DAG binding, promoting membrane dissociation. These results also concur with observations by other groups (Oancea and Meyer, 1998) , who propose that cPKC act as Ca 2+ decoders that, in a semi-open conformation, scan the membrane in search of DAG. This mode of action allows rapid, transient membrane binding and activation in response to local DAG production.
PKCa regulates TCR-mediated Ras/ERK activation
DGKf has been found to act as a negative regulator of the Ras/ ERK pathway, that is triggered after TCR activation (Zhong et al., 2003) . To assess PKCa input in DGKf-regulated events, we next monitored this signaling axis during anti-CD3/CD28 costimulation in DGKf-depleted cells. As predicted, DGKf knockdown induced Ras pathway hyperactivation as shown by MEK and ERK1/2 hyperphosphorylation. This effect was reduced by pharmacological inhibition with Gö6976, indicating that DGKf-mediated control of this pathway requires cPKC activity (Fig. 5A) . We previously reported that TCR signals induce a DGKf mobility shift, representing putative posttranslational modification. Here we observed that cPKC inhibitor treatment reduced this shift, which was more pronounced in the short isoform, suggesting cPKC-mediated regulation of DGKf.
We analyzed the specific contribution of PKCa to the control of DGKf-mediated regulation of the Ras/ERK pathway and found that, similar to inhibitor treatment, PKCa knockdown reduced TCR-mediated MEK hyperphosphorylation in DGKfdepleted cells (Fig. 5B) . The effect of PKCa depletion on pMEK was not complete, which might be attributed to incomplete PKCa knockdown or to additional components that contribute to DGKfmediated Ras/ERK activation. We hypothesized that during costimulatory signals, the function of PKCa could be compensated in part by other PKCs, such as PKCh, that is recruited to the TCR complex by CD28 (Kong et al., 2011) . We thus analyzed the effect of PKCa knockdown in T cells stimulated without CD28 co-stimulation. The impact of DGKf depletion on MEK activation was more pronounced in cells stimulated with anti-CD3 compared to anti-CD3/CD28, showing a twofold increase over siRNA control (Fig. 5C ). This hyperactivation was lost in DGKf/PKCa double-silenced cells thus showing sensitivity to PKCa expression (Fig. 5C ). These data highlight the important role of PKCa downstream of the TCR and demonstrate that, in the absence of DGKf, a greater DAG accumulation upon TCR activation promotes a PKC-driven response.
DGKf is proposed to negatively regulate the Ras/ERK pathway by modulating DAG-dependent activation of the Ras GEF RasGRP1 (Zhong et al., 2003) . To further determine the impact of PKCa on Ras regulation, we monitored Ras activation in DGKf or PKCa-silenced cells. We performed Ras-GTP pulldown assays and observed increased TCR-triggered Ras-GTP loading of DGKf-depleted cells (Fig. 5D ) after stimulation with anti-CD3 antibodies, in agreement with previous reports (Zhong et al., 2003) . PKCa knockdown blocked the gain of function effect of DGKf on Ras activation suggesting that this kinase acts upstream of Ras in a DAG-sensitive manner.
PKCa regulation of the Ras/ERK pathway contributes to CD62L shedding Activation of the Ras/ERK pathway lies at the core of several events critical for the correct onset of the T cell activation At 72 hours post-transfection, cells were left untreated or treated with the cPKC inhibitor Gö6976 (100 nM; 30 minutes) and stimulated with 1 mg/ml anti-CD3/ CD28 antibodies for indicated times. Cell extracts were analyzed by western blot and signal activation status monitored using indicated antibodies. The long (L) and the short (S) isoforms of DGKf are indicated. (B,C) Double knockdown experiments were carried out in Jurkat T cells with RNAi to DGKf and to PKCa using siRNA oligonucleotides. Cells were stimulated with 1 mg/ml anti-CD3/CD28 antibodies (B), as in A, or with 1 mg/ml anti-CD3 alone (C). To define Ras/ ERK signal activation status, cell extracts were analyzed by western blotting with specific antibodies. Representative blots are shown; graphs indicate the pMEK:MEK ratio for each time point (mean 6 s.e.m.; n$3 independent experiments). A two-way ANOVA test was applied with Bonferroni post-test: *P,0.05; **P,0.01. (D) RasGTP pull-down assays were carried out using Jurkat T cells silenced as in B and stimulated with 1 mg/ml anti-CD3 antibody for 5 minutes. Ras-GTP was isolated using GST-Raf-1-RBD beads and analyzed by western blotting.
program. We tested the functional consequences of PKCa inhibition in primary T lymphocytes by focusing on the expression of two well-characterized ERK effectors, the c-type lectin (CD69) and L-selectin (CD62L). CD69 is a bona fide Ras/ ERK/AP-1 activation marker that is transcriptionally upregulated shortly after TCR triggering (Sancho et al., 2005) . CD62L is strongly expressed on the naïve T cell surface; these levels decrease sharply after activation due to TCR-triggered ERKmediated shedding (Sinclair et al., 2008) . CD62L down-and CD69 upregulation are two hallmarks of T cell activation that take place shortly after antigen encounter and correlate closely with the antigen affinity threshold (Moreau et al., 2012) .
Mouse splenocytes were pretreated with Gö6976 or rottlerin to inhibit cPKC or nPKC respectively, then stimulated with anti-CD3 antibody; CD62L and CD69 levels were measured by flow cytometry (Fig. 6A,B) . Both inhibitors reduced CD69 expression, which was more notable after Gö6976 treatment. Rottlerin however did not prevent CD62L loss, in contrast with the neartotal blockade of CD62L shedding observed after cPKC inhibition. A detailed kinetic analysis confirmed that this effect was similar in both CD4 + and CD8 + T cells (Fig. 6B ). Phosphorylation of protein kinase D (PKD), which lies downstream of PKCa and PKCh (Spitaler et al., 2006) , was used as a control of both PKC inhibitors in western blot. Analysis confirmed the Gö6976 effect on TCR-triggered Ras/ERK pathway activation, as tested by ERK phosphorylation after long-term anti-CD3 treatment (supplementary material Fig.  S2A ); in these conditions, rottlerin had a milder effect on pERK induction. As reported (Sinclair et al., 2008) , inhibition of ERK activation with the MEK1 inhibitor (PD98059) prevented CD3-induced CD62L shedding (supplementary material Fig.  S2B ), confirming that this process is regulated by cPKC and that it requires ERK activation for an adequate response. These data corroborate our results with the human T cell line and demonstrate that cPKC regulate CD3-mediated Ras/ERK activation.
T lymphocytes from DGKf-deficient mice show hyperactivation of the Ras/ERK pathway and enhanced CD69 induction (Zhong et al., 2003) . We evaluated directly whether DGKf-dependent Ras/ERK hyperactivation also correlated with enhanced CD62L shedding, and if this gain of function was PKCa-mediated. Cell surface CD62L expression in resting WT and DGKf-deficient mouse splenocytes showed similar mean fluorescent intensities and percentage, in accordance with data from Riese et al. (Riese et al., 2011) . We observed however that the effect of DGKf deficiency on the CD62L shedding rate was associated with TCR signal strength ( Fig. 6C ; supplementary material Fig. S2C ). Our data shows that, whereas high anti-CD3 doses led to similar CD62L shedding rates in WT and DGKfdeficient mice (supplementary material Fig. S2C ), these mice showed accelerated CD62L shedding at low anti-CD3 concentrations compared to WT littermates (Fig. 6C) ; this effect was greater in CD8 + than in CD4 + T cells (not shown). For the induction of CD69, our data correlate with previous reports; at the time points and anti-CD3 concentrations tested, CD69 induction showed a slight increase in DGKf 2/2 mouse splenocytes compared to those of their WT littermates (Fig. 6D) . Again, this effect was lost at high anti-CD3 doses (supplementary material Fig. S2D ). We then tested the effect of PKC inhibition on the regulation of CD62L shedding and CD69 induction. As shown for WT T cells, CD62L shedding was blocked by Gö6976 treatment in cells from DGKf-deficient mice, and rottlerin treatment yielded no apparent effect (Fig. 6E,F) , although it delayed CD69 induction (supplementary material Fig. S2E ). These experiments confirm that DGKf-mediated DAG consumption attenuates PKCa activation downstream of the TCR and indicate a role for this isoform in TCR-mediated CD62L shedding.
Discussion
Participation of PKCa in the interplay of synapse regulation and early T cell response had been previously ruled out; the sole PKC isoform found to accumulate stably at the IS was the novel PKCh, which thus constituted an important IS marker (Tseng et al., 2008; Yokosuka et al., 2008) . Based on observations from several experimental models, we report here the direct recruitment of PKCa to the IS during T cell activation. This relocation was both rapid and transient, in contrast to the sustained accumulation of PKCh. The rapid kinetics of PKCa translocation suggests a role for this protein in membrane-linked events early after TCR triggering. In agreement with this observation, we characterized PKCa as a component of the Ras/ERK axis, and demonstrate its contribution to TCR-mediated CD62L shedding.
We observed that in response to Ca 2+ elevation, PKCa moves to the actin cytoskeleton-rich T cell/APC contact area, where it senses DAG. Pharmacological inhibitors of cPKC did not block PKCa translocation, but impaired its return to cytosol. This mechanism of action is consistent with studies showing that cPKC autophosphorylation at conserved C-terminal residues promotes membrane dissociation and autoinhibition by pseudosubstrate intramolecular binding (Newton, 2003) . Our data are also compatible with models in non-hematopoietic cell systems in which PKCa oscillates between active/open and inactive/semi-open conformations, in an equilibrium governed by DAG binding and autophosphorylation. Our findings, consistent with those of previous studies, provide a better understanding of the differences between PKCa and PKCh with respect to the signals that regulate their recruitment to the IS. Whereas PKCa senses TCR-triggered Ca 2+ and DAG generation at the IS, PKCh not only has greater affinity for DAG, but is also recruited to the IS through a protein-protein interaction between its V3 domain and CD28 (Kong et al., 2011) ; this explains why PKCh is more stable and easily detectable at the IS. The difference in kinetics between these two isoforms also helps to explain their distinct substrate specificity, with PKCa acting early and sensitive to low TCR signals, whereas PKCh controls sustained events coordinated by CD28. This mode of action correlates well with studies that showed PKCa participation in early CD3/CD28-mediated IkB kinase stimulation, followed by a later, PKChdependent activation phase (Trushin et al., 2003) . Our data show that Ras/ERK activation in response to TCR triggering was more sensitive to PKCa depletion, whereas co-stimulatory signals are less dependent on PKCa. We can foresee that the stimulation intensity could potentiate the specific activation of the classical or the novel PKC, determining the fate of the response.
Studies in non-lymphoid cells have identified DGKf as a negative regulator of PKCa, which in turn modulates DGKf activation by phosphorylation at its MARCKS (myristoylated alanine-rich C-kinase substrate) region (Luo et al., 2003) , a cluster of basic and serine residues analogous to those in the MARCKS protein.
A similar mechanism appears to operate at the IS, where DGKf and PKCa each regulates the other. Phosphorylation of the MARCKS domain seems necessary for DGKf targeting to the plasma membrane in lymphoid (Santos et al., 2002) and non-lymphoid cells (Abramovici et al., 2003) . DGKf Ser-to-Ala MARCKS domain mutants neither metabolize DAG at the IS nor prevent TCR-induced IL2 transcription . We observed a direct correlation between TCR activation and a slow-migrating DGKf band, which probably reflects post-translational modification; this effect was sensitive to PKC inhibition, as the molecular weight shift was reduced after Gö6976 co-treatment and PKCa downregulation. The previous reports combined with our findings here suggest concerted cross-regulation of PKCa and DGKf, to guarantee an adequate Ras-ERK activation threshold in response to antigen presentation. In T lymphocytes, conclusive evidence has shown the negative role for DGKf in DAG-mediated regulation of the RasGRP1/Ras axis (Roose et al., 2005) . The RasGTP generated after RasGRP1 activation binds to the Ras allosteric pocket in SOS (son of sevenless), establishing a positive feedback loop for Ras activation. RasGRP1 and SOS pathways are proposed as analog and digital determinants in the regulation of Ras activation in T lymphocytes (Das et al., 2009 ). The hyperactive Ras/ERK phenotype of DGKf-deficient mice concurs with this model, although recent experimental results suggest that the regulatory mechanism of this axis via DGKf is more complex (Riese et al., 2011) . This disparity implies that DGKf deficiency has effects other than merely promoting increased DAG/RasGRP interaction, and indicates participation of additional DAGregulated proteins. Our data identify PKCa as a DAG/DGKfregulated molecule and show its contribution to Ras GTP loading. These findings correlate with studies that describe a role for PKC in RasGRP1 regulation (Roose et al., 2005) , and pinpoint PKCa as a component in DGKf-mediated regulation of Ras activation. Additional studies are needed to determine whether PKCa modulates Ras activation through direct RasGRP1 phosphorylation. The possible regulation of RasGRP1 (which bears a DAG-binding domain and Ca 2+ -regulated EF hands) by the Ca 2+ -regulated PKCa might increase Ras/ERK pathway responsiveness to TCR-triggered PLC activation. RasGRP3 phosphorylation by PKCb2 (Teixeira et al., 2003) and regulation of Ca 2+ -dependent ERK activation by RasGRP/ PKCd and the Ca 2+ sensor STIM1 in B cells are clear examples of this type of crosstalk (Limnander et al., 2011) .
The identification of PKCa as a component of the Ras/ERK pathway correlates with a central role for this isoform in the rapid shedding of CD62L and the upregulation of CD69 that take place after TCR triggering. CD62L shedding is mediated primarily by the metalloprotease TNFa-converting enzyme (TACE/ ADAM17), although the precise mechanism governing TACEmediated CD62L shedding is not fully characterized. In addition to PKCa contribution to Ras/ERK regulation, a more direct PKCa effect on CD62L shedding correlates with previous reports that implicate PKC in the regulation of TACE-mediated shedding processes (Killock and Ivetić, 2010; Kveiborg et al., 2011) and PKCa interaction with the CD62L cytoplasmic tail after anti-CD3 stimulation (Kilian et al., 2004) .
CD62L cleavage ensures exit of activated T cells from lymph nodes and their migration to non-lymphoid organs (Arbonés et al., 1994) . This process was initially thought essential to prevent reentry of active T cells into lymph nodes (Galkina et al., 2003; Venturi et al., 2003) . Nonetheless, CD8
+ memory cells from mice transgenic for a shedding-resistant CD62L home normally to infection sites, although their virus-clearing ability is compromised (Richards et al., 2008) . A role for CD62L ectodomain proteolysis in promoting viral clearance also correlates with recent reports showing that a CD62L sheddingresistant mutant impairs CD8 + cell lytic activity following antigen recognition by tumor antigen-reactive T cells (Yang et al., 2011) . Overall, these studies suggest a biochemical link between antigen-induced loss of CD62L and CD8 + effector functions.
Our identification of PKCa at the IS and its participation in TCR-mediated signaling integrates this isoform as a component of the DAG signalosome, critical for optimal onset of the T cell activation program. Implication of the DGKf/PKCa/ERK axis in the regulation of antigen-mediated CD62L shedding, itself linked to virus clearance and anti-tumor immunity, is also consistent with the strong antiviral and anti-tumor activity in DGKfdeficient mice (Zhong et al., 2003; Riese et al., 2011) . Our study raises important questions that remain to be addressed, including the nature of the mechanisms that mediate PKCa regulation of RasGRP1/ERK, and the effect of this axis on TACE-mediated shedding of other surface molecules. Broad PKC inhibitors are being explored for manipulation of the immune response, and are in clinical trials to promote immunosuppression for organ transplant. It is thus essential to better define the impact of PKC isoforms during the immune response, to complement our current understanding of immune surveillance and to improve its therapeutic modulation.
Materials and Methods
Reagents and antibodies
Superantigen Staphylococcus enterotoxin E (SEE) was from Toxin Technology (Sarasota, FL), the cell tracker chloromethyl derivative of aminocoumarin (CMAC) and Rhodamine Phalloidin were from Molecular Probes (Life Technologies, Leiden, The Netherlands). Anti-human and -mouse CD3-e (anti-CD3) and CD28 antibodies were from BD PharMingen (San Diego, CA), crosslinking secondary antibody was from Jackson ImmunoResearch (West Grove, PA), pERK1/2, pPKD, pPLCc, pPKCa-638 from Cell Signaling Technology (Beverly, MA), monoclonal anti-PKCh antibody from BD Biosciences (San Diego, CA) and anti-PKCa from Santa Cruz Biotechnology, inc. (Santa Cruz, CA). AntiDGKf was from Abcam (Cambridge, UK) and anti-Tfr antibody from R&D Systems (Minneapolis, MN).
Cell lines and culture conditions
Human leukemic Jurkat T cells were maintained in DMEM medium (BioWhittaker, Walkersville, MD) supplemented with 10% fetal bovine serum (FBS; Sigma, St Louis, MO) and 2 mM L-glutamine (BioWhittaker). Raji human B lymphoma cells were cultured in RPMI 1640 (BioWhittaker) supplemented as above. Both cell lines were cultured at 37˚C in a 95% humidified atmosphere with 5% CO 2 and maintained at subconfluence (,5610 5 cells/ml).
Mice
Mice were maintained in pathogen-free conditions and handled in accordance with Spanish and European directives; experiments were approved by the Ethics Committee of the Centro Nacional de Biotecnologia/CSIC. OTI and DGKf 2/2 mice are described elsewhere (Hogquist et al., 1994; Zhong et al., 2003) . Experiments were carried out with 3-to 6-week-old mice; WT/DGKf-deficient mice were littermates.
Constructs and transient transfection
PKCa fused to green fluorescent protein (GFP) was a kind gift from Dr S. Corbalán-García (University of Murcia, Spain) and is reported elsewhere (Bolsover et al., 2003) . Myc-tagged DGKf fused to red fluorescent protein (RFP) or cherry, as well as C1ab-cherry and actin-cherry have been reported . Jurkat T cells in logarithmic growth were transfected as described ; briefly, 1.2610 7 cells were transfected with 25 mg plasmid DNA by electroporation using a Gene Pulser (BioRad; 270 V, 975 mF). Assays were generally performed 24 or 48 hours post-transfection.
RNA interference of DGKf and PKCa
pSUPER plasmids (Oligoengine) containing the interfering 21 nucleotide sequence of DGKf human (shRNA DGKf) or mouse (shRNA DGKa, control) in a hairpin structure were generated in our laboratory (Avila-Flores et al., 2005; Rincón et al., 2011) . siRNA oligonucleotides used to silence PKCa have been described (Lønne et al., 2010) and siRNA to silence DGKf corresponds to the same region as the shRNA to DGKf. Jurkat T cells in logarithmic growth were transfected with 25 mg plasmid DNA or with siRNA oligonucleotides by electroporation as above. In overexpression experiments, PKCa-GFP was electroporated 48 hours after RNA interference (RNAi). Cells were assayed by time-lapse microscopy at 72-96 hours post-RNAi treatment.
Anti-CD3 and anti-CD3/CD28 stimulation For TCR stimulation, Jurkat T cells in logarithmic growth were pooled (10 7 cells in 1 ml of medium/condition) and held on ice (10 minutes). Cells were stimulated with soluble anti-CD3 or anti-CD3/CD28 antibodies (1 mg/ml) for indicated times and lysed (1% Igepal, 150 mM NaCl, 20 mM Hepes, pH 7.4, supplemented with protease and phosphatase inhibitors sodium orthovanadate, b-glycerophosphate, phenylmethylsulfonyl fluoride, leupeptin and aprotinin) for western blot of total cell extracts. Where indicated, cells were pretreated for pharmacological inhibition with bisindolylmaleimide (BIM) (100 nM), Gö6976 (100 nM), rottlerin (6 mM) or PD98059 (50 mM or 2 mM) (37˚C, 30 minutes) prior to stimulation (all from Calbiochem, MERCK-Millipore, Darmstadt, Germany).
Membrane fractionation
Jurkat T cells were fractionated as described (Merino et al., 2008) . Cells were incubated on ice with 5 mg/ml anti-CD3 alone or combined with 5 mg/ml anti-CD28 antibody (30 minutes). Secondary crosslinking antibody (20 mg/ml) was added to anti-CD3/CD28-coated cells (10 minutes, on ice), and transferred to 37˚C during time course of stimulation. Cells were lysed in digitonin lysis buffer [40 mg/ ml digitonin, 5 mM Tris-HCl pH 7.5, 10 mM NaCl, 0.5 mM MgCl 2 , 1 mM EGTA, 1 mM dithiothreitol (DTT), supplemented with protease and phosphatase inhibitors] for 15 minutes on ice. Cytosol was collected after centrifugation (4500 g, 4 minutes, 4˚C) and pellets were further solubilized in NP-40 lysis buffer (0.2% Igepal, 5 mM Tris-HCl pH 7.5, 10 mM NaCl, 0.5 mM MgCl 2 , 1 mM EGTA, 1 mM DTT) for 10 minutes on ice. Membrane fractions were separated from insoluble fractions by centrifugation (15,0006g, 15 minutes, 4˚C). Each fraction was quantified by Bradford assay and analyzed by western blot.
Ras pull-down assays
Jurkat T cells were transfected with interfering nucleotides and assayed 72 hours post-RNAi treatment; 3610 6 cells/condition were stimulated with 1 mg/ml anti-CD3 (5 minutes). Cells were pelleted, resuspended in 150 ml Mg-containing buffer (MLB: 25 mM HEPES, pH 7.5, 150 mM NaCl, 1% Igepal, 10 mM MgCl 2 , 1 mM EDTA, 2% glycerol) supplemented with protease inhibitors and lysed by 15 passages through a 30-gauge needle. The suspension was cleared by centrifugation (13,0006g, 15 minutes, 4˚C) and the supernatant pre-cleared with glutathione S-transferase (GST)-agarose beads (10 minutes, 4˚C). Lysate (150 mg) was incubated (30 minutes) with 10 ml GST-Raf 1-Ras-binding domain beads (GST-Raf-1-RBD; Upstate Biotechnology, Lake Placid, NY). Beads were washed three times with MLB buffer and eluted by boiling in SDS-PAGE loading buffer. Eluted proteins were analyzed by immunoblot using a pan-Ras mAb (Oncogene) to detect bound Ras.
Immunostaining
T cells (2.5610 5 cells) untransfected or at 48 hours post-transfection with PKCa-GFP, were transferred to poly-DL-lysine-coated coverslips (10 minutes, on ice). Where indicated, cells were pretreated with 100 nM BIM (15 minutes, 37˚C). Raji B cells (2610 7 cells/ml) were stained with 50 mM CMAC and incubated alone or with 1 mg/ml SEE (30 minutes, 37˚C), then added as droplets at a 1:1 ratio to Jurkat T cells on ice to capture early reaction kinetics. Jurkat T cells/APC were incubated (37˚C, 5 minutes). Immunostaining was performed as described (Cernuda-Morollón et al., 2010) . Cells were then fixed (4% paraformaldehyde), washed and permeabilized (5 minutes, on ice) in 0.2% Triton/PBS, then blocked in 5% BSA/PBS. Specific antibodies were used as stated in figure legends (30 minutes, 37˚C). For experiments with primary T lymphocytes, spleen cells from OTI mice were presented with the EL4 mouse lymphoma cell line, loaded with the OVA peptide and pre-stained with 50 mM CMAC. CTL/EL4 were incubated (10 minutes, 37˚C). Mounted slides were analyzed by confocal microscopy (LSM-510 META, Zeiss) and images processed with ImageJ and Adobe Photoshop software.
Time-lapse confocal microscopy
Live Jurkat cells were imaged as described, with minor modifications . Briefly, at 48 or 72 hours post-transfection, cells were collected (0.5610 6 cells/ml) in HBSS (25 mM HEPES-KOH pH 7.4, 1 mM MgCl 2 , 1 mM CaCl 2 , 132 mM NaCl, 0.1% BSA) supplemented with 2% FBS. Cells were transferred to poly-DL-lysine-coated glass chambers (Nunc, Lab-Tek, Rochester, NY) and placed on a 37˚C stage of a laser-scanning confocal microscope (FV1000, Olympus). Images were collected every 10 seconds before, during and after addition of control or SEE-pulsed Raji B cells stained with CMAC (added as droplets from 2610 7 cells/ml in HBSS). Videos were analyzed using image analysis software (ImageJ v1.45q). PKCa-GFP time of translocation was quantified by measuring the accumulation time of GFP-positive signals at the IS for each condition tested. Data were averaged from at least 15 videos per condition. For fluorescence IS signal quantification, GFP-fluorescence intensity ratios at the IS versus the cytosol were measured using an ImageJ plug-in developed in-house (C. Sorzano, CNB/CSIC) .
Primary splenocyte stimulation and analysis of cell surface receptors T cells were isolated from spleen, collected in RPMI (5% L-glutamine, 10% FBS) and maintained at 37˚C in 5% CO 2 throughout the assays. Cells (2610 6 cells/ml) pretreated with specific inhibitors or vehicle were stimulated with 5 or 2.5 mg/ml anti-CD3 antibodies for up to 4 hours. Cells were collected in ice-cold PBS and surface-stained for FACS analysis or western blot. For flow cytometry, cell surface receptors were stained with saturating concentrations of fluorophore-conjugated antibodies (CD4-APC, CD8-PeCy7, CD62L-FITC, CD69-PE, from BD Pharmingen or eBiosciences, San Diego, CA) in PBS staining buffer (0.5% BSA/PBS) (30 minutes, 4˚C). Cells were washed, fixed in 0.2% paraformaldehyde/0.5% BSA/PBS, and held at 4˚C for flow cytometry using Gallios and Cytomix FC500 cytometers (Beckman Coulter Inc.). Live cells were gated using forward and side scatter parameters. Each sample was acquired for a minimum of 70,000 events and data were analyzed using FlowJo software (TreeStar, Ashland, OR).
Fig. S1. Immunofluorescence analysis of endogenous PKCα during antigen presentation with SEE-loaded Raji B cells (APC; blue). (A,B)
Jurkat T cells were incubated onto poly-Lysine-coated slides for 10 min. They were then placed on ice and CMACstained/SEE loaded APCs (star) were added as droplets, to allow cells to adhere to the coverslips, without initiation of antigen presentation. T-B cells were then incubated at 37°C, 5% CO 2 incubator for 5 min and fixed with paraformaldehyde. Permeabilized cells were probed with PKCα (A) or pPKCα (Thr-638) (B) antibodies. Polymerized actin and PKCθ were used as markers of T/B cell conjugate with Rhodamin Phalloïdin and anti-PKCθ antibody. Representative images are shown for PKCα staining, and pPKCα staining. In cells transfected with PKCθ-GFP (B), we detected PKCα/PKCθ co-localization, suggesting that both enzymes are not exclusive. (C) Splenocytes from OT-I mice were incubated for 10 min with EL-4 T cells loaded with the peptide OVA antigen (star). Cells were fixed and stained with antibodies to PKCα, PKCθ and polymerized actin (Rhodamin Phalloïdin), as in panel A. Scale bars: 5 μm (A); 10 μm (B).
